ELION THERAPEUTICS Trademark

Trademark Overview


On Thursday, December 14, 2023, a trademark application was filed for ELION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELION THERAPEUTICS trademark a serial number of 98314270. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 22, 2025. This trademark is owned by Sfunga Therapeutics, Inc.. The ELION THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infective medications; Anti-fungal medications for administration by a healthcare professional in a healthcare setting to treat systemic fungal infections or invasive fungal disease

General Information


Serial Number98314270
Word MarkELION THERAPEUTICS
Filing DateThursday, December 14, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2025

Trademark Statements


Goods and ServicesAnti-infective medications; Anti-fungal medications for administration by a healthcare professional in a healthcare setting to treat systemic fungal infections or invasive fungal disease
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameELION THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10010

Party NameELION THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10010

Party NameSfunga Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10010

Trademark Events


Event DateEvent Description
Thursday, December 14, 2023NEW APPLICATION ENTERED
Wednesday, March 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 8, 2024NON-FINAL ACTION E-MAILED
Monday, July 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 5, 2024ASSIGNED TO EXAMINER
Monday, July 8, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, January 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 22, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED